{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:24:37Z","timestamp":1765887877643},"reference-count":38,"publisher":"The Journal of Rheumatology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To investigate endocrine comorbidities in patients with psoriatic arthritis (PsA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>A retrospective, cross-sectional study was performed with the database of Clalit Health Services, the largest healthcare provider in Israel, between 2002 and 2014. Patients with PsA were identified and matched by age and sex to healthy controls. The following morbidities were analyzed: hypo\/hyperthyroidism, hypo\/hyperparathyroidism, hyperprolactinemia, Cushing disease, Addison disease, diabetes insipidus, diabetes mellitus (DM), pituitary adenoma, acromegaly, and osteoporosis. Descriptive statistics were applied. The associations between PsA and endocrine comorbidities were analyzed by univariable and multivariable analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The study included 3161 patients with PsA, 53.4% women, mean age 58.4 \u00b1 15.4 years, and 31,610 controls. Comparative analyses yielded higher proportion of hypothyroidism (12.7% vs 8.6%, p &lt; 0.0001), Cushing disease (0.3% vs 0.1%, p &lt; 0.0001), osteoporosis (13.2% vs 9.1%, p &lt; 0.0001), and DM (27.9% vs 20.7%, p &lt; 0.0001) in the PsA group compared with the control group. In the multivariable regression analysis, the following diseases were more frequent in the PsA group: hypothyroidism (OR 1.61, 95% CI 1.47\u20131.81), DM (OR 1.35, 95% CI 1.18\u20131.42), Cushing disease (OR 3.96, 95% CI 1.67\u20139.43), and osteoporosis (OR 1.56, 95% CI 1.37\u20131.78).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>PsA is associated with a high frequency of hypothyroidism, osteoporosis, DM, and Cushing disease. Awareness of these comorbidities may help physicians provide the optimal medical care to patients with PsA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.161274","type":"journal-article","created":{"date-parts":[[2017,4,16]],"date-time":"2017-04-16T00:10:12Z","timestamp":1492301412000},"page":"786-790","source":"Crossref","is-referenced-by-count":14,"title":["Endocrine Comorbidities in Patients with Psoriatic Arthritis: A Population-based Case-controlled Study"],"prefix":"10.3899","volume":"44","author":[{"given":"Amir","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron Ilan","family":"Ashkenazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haim","family":"Bitterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Feldhamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sari","family":"Greenberg-Dotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idit","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erez","family":"Batat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon Dov","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2017,4,15]]},"reference":[{"key":"2018112909370426000_44.6.786.1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","article-title":"Comorbidities in psoriatic arthritis","volume":"41","author":"Husni","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"key":"2018112909370426000_44.6.786.2","unstructured":"World Health Organization . Global status report on noncommunicable diseases 2014. [Internet. Accessed March 3, 2017.] Available from: www.who.int\/nmh\/publications\/ncd-status-report-2014\/en"},{"key":"2018112909370426000_44.6.786.3","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldr030"},{"key":"2018112909370426000_44.6.786.4","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-14-9"},{"key":"2018112909370426000_44.6.786.5","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0136-1"},{"key":"2018112909370426000_44.6.786.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.068130"},{"key":"2018112909370426000_44.6.786.7","first-page":"2026","article-title":"High prevalence of thyroid autoimmunity and hypothyroidism in patients with psoriatic arthritis","volume":"33","author":"Antonelli","year":"2006","journal-title":"J Rheumatol"},{"key":"2018112909370426000_44.6.786.8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13075-016-0928-y","article-title":"Co-morbidity in patients with early rheumatoid arthritis - inflammation matters","volume":"18","author":"Innala","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2018112909370426000_44.6.786.9","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-2-13"},{"issue":"Suppl 10","key":"2018112909370426000_44.6.786.10","first-page":"1697","article-title":"Validity of diagnostic codes and point prevalence of psoriatic arthritis in Israel \u2013 a population-based study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2018112909370426000_44.6.786.11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205148"},{"key":"2018112909370426000_44.6.786.12","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s10067-016-3374-y","article-title":"Gastrointestinal comorbidities in patients with psoriatic arthritis","volume":"35","author":"Zohar","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2018112909370426000_44.6.786.13","first-page":"404","article-title":"Prevalence of selected chronic diseases in Israel","volume":"3","author":"Rennert","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"2018112909370426000_44.6.786.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.10.016"},{"key":"2018112909370426000_44.6.786.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.08.040"},{"key":"2018112909370426000_44.6.786.16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22185"},{"key":"2018112909370426000_44.6.786.17","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200567"},{"key":"2018112909370426000_44.6.786.18","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12473"},{"key":"2018112909370426000_44.6.786.19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaad.2015.02.1095","article-title":"Psoriasis and risk of diabetes-associated microvascular and macrovascular complications","volume":"72","author":"Armstrong","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2018112909370426000_44.6.786.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140021"},{"key":"2018112909370426000_44.6.786.21","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken090"},{"key":"2018112909370426000_44.6.786.22","first-page":"563","article-title":"Psoriasis and the metabolic syndrome","volume":"7","author":"Gottlieb","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"2018112909370426000_44.6.786.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2008.01217.x"},{"key":"2018112909370426000_44.6.786.24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/oby.2004.24","article-title":"A novel pathway to the manifestations of metabolic syndrome","volume":"12","author":"Sonnenberg","year":"2004","journal-title":"Obes Res"},{"key":"2018112909370426000_44.6.786.25","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-007-0025-3"},{"key":"2018112909370426000_44.6.786.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2007.04.009"},{"key":"2018112909370426000_44.6.786.27","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2007.053595"},{"key":"2018112909370426000_44.6.786.28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1517\/13543784.13.3.215","article-title":"Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis?","volume":"13","author":"Pershadsingh","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"2018112909370426000_44.6.786.29","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.448"},{"key":"2018112909370426000_44.6.786.30","first-page":"77","article-title":"In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density","volume":"33","author":"Rossini","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909370426000_44.6.786.31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/BOR.0b013e3283620777","article-title":"Osteoporosis and vertebral fractures in ankylosing spondylitis","volume":"25","author":"Davey-Ranasinghe","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"2018112909370426000_44.6.786.32","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140919"},{"issue":"Suppl 86","key":"2018112909370426000_44.6.786.33","first-page":"S-28","article-title":"Bone disease in systemic sclerosis: outcomes and associations","volume":"32","author":"Omair","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909370426000_44.6.786.34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4081\/reumatismo.2014.785","article-title":"Osteoporosis and rheumatic diseases","volume":"66","author":"Maruotti","year":"2014","journal-title":"Reumatismo"},{"key":"2018112909370426000_44.6.786.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-011-0095-8"},{"key":"2018112909370426000_44.6.786.36","first-page":"138","article-title":"Bone mineral density in patients with psoriatic arthritis","volume":"28","author":"Frediani","year":"2001","journal-title":"J Rheumatol"},{"key":"2018112909370426000_44.6.786.37","doi-asserted-by":"publisher","DOI":"10.1007\/BF02054256"},{"key":"2018112909370426000_44.6.786.38","first-page":"1430","article-title":"Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation","volume":"29","author":"Grisar","year":"2002","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.161274","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:18:05Z","timestamp":1543519085000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.161274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,15]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,1]]},"published-print":{"date-parts":[[2017,6]]}},"alternative-id":["10.3899\/jrheum.161274"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.161274","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,15]]}}}